Table 2.
Estradiol uniquely downregulates signaling pathways in activated SLE T cells but not in normal T cells. Gene lists that were generated from microarray data were analyzed for pathways uniquely downregulated in all SLE T cells and not in the control T cells. List shown is of pathways which met the criteria for significance (p ≤ 0.05) in SLE T cells.
Pathway | SLE T cells p-value | Control T cells p-value |
---|---|---|
PPARα/RXRγ Activation | 0.0006 | NS |
G-Protein Coupled Receptor Signaling | 0.0017 | NS |
Hepatic Fibrosis/Hepatic Stellate Cell Activation | 0.0019 | NS |
cAMP-mediated Signaling | 0.0024 | NS |
Nitrogen Metabolism | 0.0058 | NS |
Propanoate Metabolism | 0.0102 | NS |
Circadian Rhythm Signaling | 0.0120 | NS |
Axonal Guidance Signaling | 0.0174 | NS |
Keratan Sulfate Biosynthesis | 0.0234 | NS |
Calcium Signaling | 0.0275 | NS |
Fatty Acid Metabolism | 0.0282 | NS |
Valine, Leucine and Isoleucine Degradation | 0.0309 | NS |
Cardiac β2-adrenergic Signaling | 0.0324 | NS |
β-alanine Metabolism | 0.0417 | NS |
Phospholipid Degradation | 0.0417 | NS |
Synaptic Long Term Potentiation | 0.0437 | NS |
LPS/IL-1 Mediated Inhibition of RXR Function | 0.0437 | NS |
TGF-β Signaling | 0.0447 | NS |
IL-2 Signaling | 0.0457 | NS |
Amyloid Processing | 0.0457 | NS |